These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 16494720)

  • 1. Vaccines for pandemic influenza.
    Luke CJ; Subbarao K
    Emerg Infect Dis; 2006 Jan; 12(1):66-72. PubMed ID: 16494720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines.
    Wkly Epidemiol Rec; 2006 Aug; 81(34/35):328-30. PubMed ID: 16933379
    [No Abstract]   [Full Text] [Related]  

  • 3. Strategies for developing vaccines against H5N1 influenza A viruses.
    Horimoto T; Kawaoka Y
    Trends Mol Med; 2006 Nov; 12(11):506-14. PubMed ID: 17011235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a mucosal vaccine for influenza viruses: preparation for a potential influenza pandemic.
    Hasegawa H; Ichinohe T; Tamura S; Kurata T
    Expert Rev Vaccines; 2007 Apr; 6(2):193-201. PubMed ID: 17408369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genesis of pandemic influenza.
    Sorrell EM; Ramirez-Nieto GC; Gomez-Osorio IG; Perez DR
    Cytogenet Genome Res; 2007; 117(1-4):394-402. PubMed ID: 17675883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. H5N1 outbreaks and enzootic influenza.
    Webster RG; Peiris M; Chen H; Guan Y
    Emerg Infect Dis; 2006 Jan; 12(1):3-8. PubMed ID: 16494709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenic and genetic characteristics of H5N1 viruses and candidate H5N1 vaccine viruses developed for potential use as pre-pandemic vaccines, March 2007.
    Wkly Epidemiol Rec; 2007 May; 82(19):164-7. PubMed ID: 17500103
    [No Abstract]   [Full Text] [Related]  

  • 8. Live attenuated vaccines for pandemic influenza.
    Chen GL; Subbarao K
    Curr Top Microbiol Immunol; 2009; 333():109-32. PubMed ID: 19768402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an attenuated H5N1 avian influenza virus vaccine with all eight genes from avian viruses.
    Shi H; Liu XF; Zhang X; Chen S; Sun L; Lu J
    Vaccine; 2007 Oct; 25(42):7379-84. PubMed ID: 17870216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus.
    Khurana S; Chearwae W; Castellino F; Manischewitz J; King LR; Honorkiewicz A; Rock MT; Edwards KM; Del Giudice G; Rappuoli R; Golding H
    Sci Transl Med; 2010 Jan; 2(15):15ra5. PubMed ID: 20371470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic and genetic characteristics of influenza A(H5N1) and influenza A(H9N2) viruses for development of candidate vaccines viruses for pandemic preparedness - February 2011.
    Wkly Epidemiol Rec; 2011 Mar; 86(11):93-100. PubMed ID: 21395189
    [No Abstract]   [Full Text] [Related]  

  • 12. Pandemic H5N1 influenza vaccine development: an update.
    El Sahly HM; Keitel WA
    Expert Rev Vaccines; 2008 Mar; 7(2):241-7. PubMed ID: 18324892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aflunov(®): a prepandemic influenza vaccine.
    Gasparini R; Amicizia D; Lai PL; Panatto D
    Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing vaccines for pandemic influenza.
    Horimoto T; Kawaoka Y
    Curr Top Microbiol Immunol; 2009; 333():165-76. PubMed ID: 19768405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines for a potential influenza pandemic.
    Auewarakul P; Thongcharoen P
    Future Microbiol; 2007 Jun; 2(3):345-9. PubMed ID: 17661708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Avian Influenza Virus A(H5Nx) and Prepandemic Candidate Vaccines: State of the Art.
    Focosi D; Maggi F
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are we ready for pandemic influenza H5N1?
    Stephenson I
    Expert Rev Vaccines; 2005 Apr; 4(2):151-5. PubMed ID: 15889987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention and control of highly pathogenic avian influenza with particular reference to H5N1.
    Capua I; Cattoli G
    Virus Res; 2013 Dec; 178(1):114-20. PubMed ID: 23611921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparing for a possible pandemic: influenza A/H5N1 vaccine development.
    Keitel WA; Atmar RL
    Curr Opin Pharmacol; 2007 Oct; 7(5):484-90. PubMed ID: 17644429
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential.
    Desheva JA; Lu XH; Rekstin AR; Rudenko LG; Swayne DE; Cox NJ; Katz JM; Klimov AI
    Vaccine; 2006 Nov; 24(47-48):6859-66. PubMed ID: 17050041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.